AstraZeneca describes use of 4-aminoquinazoline derivatives in the treatment of solid tumors Jan. 31, 2002
Effect of RPR-115135 on cytotoxicity of 5-FU in human tumor cells with different p53 status Jan. 31, 2002
RSS